GlaxoSmithKline set to exit Nigeria after 51 years of operation
GlaxoSmithKline (GSK), a British pharmaceutical and biotechnology company, has announced its plan to exit Nigeria after 51 years of operation in Nigeria.
However, GSK Nigeria, in a statement by its secretary, Fredrick Ichekwai, said the exit would be in the coming months. The statement was sent to the Nigeria Exchange Limited (NGX).
The company said it resolved to exit the West African country after its board meeting and evaluation of options with GSK UK.
“The board of GlaxoSmithKline Consumer Nigeria Plc has concluded that there is no alternative but to cease operations,” GSK Nigeria said.
The development comes two months after the company lamented the difficulty in accessing currency, stating that it affected its supply of products to Nigeria.
“The challenge in accessing currency is affecting our ability to maintain a consistent supply of medicines and vaccines in the market,” it said in a statement by its spokesperson, Omongiade Ehighebolo.
Nonetheless, the company, in its latest statement, said it would appoint third-party distributors to supply medicines and healthcare products in Nigeria.
“The Haleon Group has also separately informed the board of its intent to terminate its distribution agreement in the coming months and to appoint a third-party distributor in Nigeria for the supply of its consumer healthcare products,” it said.
GSK Nigeria said it would ensure it meets legal requirements on the development with its employees and shareholders.
It advised shareholders to seek professional advice and exercise caution when dealing with the company’s shares until a further announcement.
“The Board is conscious that shareholders will have many questions; we have been working assiduously with our professional advisors to agree on the next steps, and we will be shortly submitting to the Securities and Exchange Commission (“SEC”) a draft Scheme of Arrangement which may if approved, see shareholders other than GSK UK, receive an accelerated cash distribution and return of capital,” it said.
GlaxoSmithKline Consumer Nigeria Plc was incorporated in Nigeria on June 23, 1971, and commenced business on July 1, 1972, under Beecham Limited.
The company was quoted on the Nigerian Stock Exchange in 1977.
We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.
More from Peoples Gazette
States
Independence: NBA urges Nigerians to expect better future
The NBA said that ordinary Nigerians should be deriving benefit from the subsidy removal rather than hardship.
Agriculture
FG tasks ECOWAS on leveraging financing strategies for agroecology
The federal government has urged stakeholders in the agriculture and finance sectors in the West Africa region to leverage financing strategies to enhance agroecology practices
Politics
Katsina youths pledge to deliver over 2 million votes to Atiku
“Katsina State is Atiku’s political base because it is his second home.”
World
El Niño could push 45 million more into acute hunger by end of 2027, WFP warns
The WFP said its operations and innovations reached 132.5 million people in 75 countries and territories last year.
Lagos
Lagos to divert traffic for Ozumba Mbadiwe Road rehabilitation from October 19
The commissioner implored motorists to plan their movement, obey traffic officials, and cooperate with the interventions put in place to ease traffic.
States
Kaduna SSG counsels governing board members to operate within law
Mr Meyere pointed out that a board or council provides policy direction and oversight, while day-to-day administration remains the responsibility of the management.
Economy
NBRDA, EHCON explore biogas solution to abattoir waste challenge
Nigeria’s abattoir waste could become a source of renewable energy under a new partnership between two agencies seeking better environmental management, authorities have said.
Economy
Liberia launches 2026 offshore licensing round, offering 15 blocks to investors
Qualified companies are invited to negotiate offshore exploration opportunities, with submissions closing April 15, 2027.
World
EU Summit: Merz demands increased funds for Ukraine
German Chancellor Friedrich Merz called for increased financial support for Ukraine as EU leaders convened for a summit in Brussels.
